Warning letter
AnazaoHealth Corporation: warning letter of Dec 9, 2015
FDA warning letter 460480 · San Francisco District Office
Key facts
| Reference number | 460480 |
|---|---|
| Company | AnazaoHealth Corporation |
| Subject | Unapproved New Drug/Compounding/Misbranding/Adulterated |
| Issue date | Dec 9, 2015 |
| Posted date | Feb 9, 2016 |
| Issuing office | San Francisco District Office |
| Product type | Drugs |
| CFR sections cited | 211.160(b), 201.115, 211.192, 200.10(b), 211.113(b), 210.1(b) |
| Inspection city | Las Vegas |
| Inspection ZIP | 89113 |
| Inspection start date | Jan 20, 2015 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: